October 2022 Injectable PrEP Update
October 2022 Injectable PrEP Update
October 13, 2022
Resource Type: Webinar
August 17, 2022
Description:
Since the first HPV vaccines were introduced in 2006, rates of cervical cancer and other HPV-related cancers have decreased in immunized populations. Family PACT will add HPV immunization as a benefit in July 2022 and will utilize guidelines developed by the CDC Advisory Committee of Immunization Practices (ACIP). This webinar will provide information about the effectiveness and safety of the HPV vaccine, review the current CDC recommendations for the use of the 9-valent HPV vaccine, and provide advice on how to have effective shared decision-making conversations with clients about being immunized. In addition, new Family PACT policies about coding and billing for HPV immunization services will be discussed. There will be ample time for your questions at the end of the presentation.
Learning Objectives:
• List 2 effective strategies for engaging with patients who have vaccine hesitancy
• Demonstrate a person-centered technique for providing a strong recommendation without coercion
• Describe the impact of HPV vaccination on the natural history of HPV
• Discuss the safety profile of HPV vaccines
Speakers:
Assistant Clinical Professor
UCLA School of Nursing
President, Envision SRH
Professor Emeritus, UCSF
Senior Medical Advisor, CAPTC and California OFP
Clinical Fellow, NFPRHA
Resources:
Transcript: Talking with Family PACT Clients About HPV Immunization
Slide deck: Talking with Family PACT Clients About HPV Immunization
Q and A: Talking with Family PACT Clients About HPV Immunization
July 2022 Seminar on Injectable PrEP Financing and Logistics
July 2022 Seminar on Injectable PrEP Financing and Logistics
STI Clinical Update Webinar – Neurosyphilis
Thursday, July 21, 2022, 11:30 AM – 1:00 PM (PDT)
The California Department of Public Health (CDPH) continues to see dramatic statewide increases in syphilis. Neurosyphilis, a syphilitic infection of the nervous system, poses a complex diagnostic and management challenge for providers caring for patients with syphilis. This webinar features Drs. Kathleen Jacobson, Chief of the CDPH Sexually Transmitted Diseases Control Branch and Sue Tuddenham, Assistant Professor of Medicine at the Johns Hopkins University School of Medicine, who will discuss the epidemiology, diagnosis and management of neurosyphilis.
Learning Objectives:
- Review California and national epidemiology of neurosyphilis
- Describe the pathophysiology of neurosyphilis
- Delineate clinical diagnosis and management of patients with neurosyphilis
May 11, 2022
Over the last year, the Family PACT Program has added several new benefits. These include three new contraceptive methods, a diagnostic test for Mycoplasma genitalium, and modifications in STI treatments based on the 2021 CDC STI Treatment Guidelines. In this webinar, a description of the new benefits will be provided and the Family PACT policies that relate to their utilization will be discussed. There will be ample time to ask questions regarding these and other Family PACT benefits.
Learning Objectives:
- Describe and explain the three new contraceptive methods and explain how to discuss the advantages and disadvantages of each with Family PACT clients
- List three circumstances when the use of the diagnostic test for Mycoplasma genitalium is clinically indicated
- Describe four modifications in STI treatments based on the 2021 CDC STI Treatment Guidelines
Speakers:
- Michael Policar, MD, MPH
Professor Emeritus, UCSF
Senior Medical Advisor, CAPTC and California OFP
Clinical Fellow, NFPRHA
Resources:
- Handout – Medicaid and CHIP Continuous Enrollment Unwinding Toolkit
- Handout – Medi-Cal Continuous Coverage Requirement Toolkit
- Transcript – Putting New Family PACT Benefits to Work in Patient Care
- Webinar Q & A – Putting New Family PACT Benefits to Work in Patient Care
- Webinar slides – Putting New Family PACT Benefits to Work in Patient Care
April 2022 Seminar on PrEP Financing and Logistics
April 2022 Seminar on PrEP Financing and Logistics
April 28, 2022
STI Clinical Update Webinar: Dermatologic Manifestations of STIs
May 27, 2022
Presented by Ken Katz, MD
What you see is what they’ve got! Come learn about mucocutaneous signs and symptoms of sexually transmitted infections.
Learning Objectives
- Evaluate mucocutaneous manifestations of STIs.
- Apply knowledge about mucocutaneous manifestations of STIs to diagnosis and management of patients.
STI Expert Hour Webinar: Herpes Simplex Virus Infections – It’s Complicated
May 2, 2022
Presented by: Christine Johnston, MD, MPH, FIDSA and Terri Warren, BA, BSN, MEd, MSN
This webinar will focus on understanding the complex situation with herpes diagnostics—who to test, when to test, how to interpret tests, and how to obtain better tests. We will also discuss developments in new treatments and prevention methods and briefly touch on herpes counseling.
Learning Objectives:
- Participants will be able to discuss the limitations of currently available serologic diagnostic testing and how to optimize testing using a patient-centered approach.
- Participants will understand the current landscape of new and current HSV therapeutics.
- Participants will be able to state five key messages that should be included in counseling patients with a new or existing diagnosis of genital herpes.
STI Expert Hour Webinar: Addressing Systemic Racism in Sexual Health Settings
February 10, 2022
Presented by Leo Moore, MD, MSHPM
Social determinants of health grounded in racism may contribute to adverse sexual and reproductive health outcomes. This webinar will discuss some of the systemic and individual-level influences on the sexual health care experience that can result in medical mistrust. We will also discuss opportunities and provide evidence-based recommendations to promote health equity in sexual health care for patients from communities of color.
Learning objectives
- Describe two social determinants of health that may be affected by systemic racism.
- Discuss at least one intervention that can be implemented to improve health equity in sexual health care settings.
STI Expert Hour Webinar: Why the Dose Matters: PrEP Strategies for HIV
January 11, 2022
Presented by Katherine Yang, PharmD, MPH
Pre-Exposure prophylaxis (PrEP) has been shown to be safe and effective in reducing HIV infection. With recent updates in PrEP, many options are available, and selection of the best regimen is the key to success. The purpose of this webinar is to review the pharmacologic basis for drug dosing and outline gaps and challenges in management.
Learning objectives
- Review the key pharmacokinetic and pharmacodynamic properties of emtricitabine/tenofovir disoproxil fumarate, emtricitabine/tenofovir alafenamide, and cabotegravir.
- Identify patients who may be appropriate for Daily vs. Event-Driven PrEP.
- Review key side effects of PrEP and potential strategies for management.
- Describe the role of adherence on PrEP effectiveness.